MGD014 in HIV-Infected Individuals on Suppressive Antiretroviral Therapy
Is a
Allocation Type
Non-Randomized
0
Intervention Model
Sequential Assignment
0
Intervention Name
MGD014
0
Interventional Trial Phase
Phase 1
0
Interventional Trial Purpose
Treatment
0
Intervention Type
Biological
0
Last Updated
September 2, 2022
0
Masking Type
None (Open Label)
0
Primary Completion Date
September 28, 2021
0
Trial Recruitment Size
21
0
Trial Sponsor
Clinical Trial Start Date
September 25, 2018
0
Study Completion Date
September 28, 2021
0
Clinical Trial Study Type
Interventional
0
NCT Number
Official Name
A Phase 1 Study to Evaluate the Safety, Immunologic and Virologic Responses of MGD014 Therapy in HIV-Infected Individuals on Suppressive Antiretroviral Therapy
0
Official Website
Find more entities like MGD014 in HIV-Infected Individuals on Suppressive Antiretroviral Therapy
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
By using this site, you agree to our Terms of Service.